Risks of Bleeding and Clotting Increase with Age

Risks of Bleeding and Clotting Increase with Age
Published Online: Thursday, December 1, 2005

A recent study by Dutch researchers highlighted the dilemma many practitioners face when treating elderly patients. Approximately 4200 patients were included in the study, which was designed to examine the risks of bleeding or thromboembolism in elderly subjects treated with anticoagulation. The risk of major hemorrhage rose from 1.5 per 100 patient-years in people younger than 60 years, to 4.2 per 100 patient-years in subjects older than 80 years. In addition, the risk of thromboembolic events more than doubled when the 2 groups were compared. This higher risk of clotting problems in the elderly often necessitates anticoagulation therapy, which then creates bleeding risk. The researchers suggested that further studies should focus on ways to lower bleeding risk in these high-risk patients.

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.

Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues